Trillium Therapeutics' lead compound is SIRPI Fc, which blocks CD47, the "don't eat me" signal on cancer cells which prevents immune-mediated cancer cell killing.
http://ift.tt/1m0paG8
http://ift.tt/1m0paG8
Stem Cell Research News: News on Stem Cell Research continually updated from thousands of sources around from the B Media Network.
No comments:
Post a Comment